BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 2950941)

  • 21. [Interaction of fibrinogen with two forms of fibrin differing in the degree of activation by thrombin].
    Belitser VA; Lugovskoĭ EV; Ugarova TP; Derzskaia SG
    Biokhimiia; 1985 Aug; 50(8):1336-41. PubMed ID: 4074798
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Action of proteolytic enzymes on fibrinogen].
    Jamet M; Levy G
    Ann Anesthesiol Fr; 1978; 19(8):687-91. PubMed ID: 31111
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fibrin polymerization and release of fibrinopeptide B by thrombin.
    Hurlet-Jensen A; Cummins HZ; Nossel HL; Liu CY
    Thromb Res; 1982 Aug; 27(4):419-27. PubMed ID: 7147212
    [No Abstract]   [Full Text] [Related]  

  • 24. Localization of a fibrin polymerization site.
    Olexa SA; Budzynski AZ
    J Biol Chem; 1981 Apr; 256(7):3544-9. PubMed ID: 6451630
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evidence for four different polymerization sites involved in human fibrin formation.
    Olexa SA; Budzynski AZ
    Proc Natl Acad Sci U S A; 1980 Mar; 77(3):1374-8. PubMed ID: 6929491
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The release of B beta 1-42 from fibrinogen and fibrin by plasmin.
    Hurlet-Jensen A; Koehn JA; Nossel HL
    Thromb Res; 1983 Mar; 29(6):609-17. PubMed ID: 6222508
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sialic acid in fibrinogen: effects of sialic acid on fibrinogen-fibrin conversion by thrombin and properties of asialofibrin clot.
    Okude M; Yamanaka A; Morimoto Y; Akihama S
    Biol Pharm Bull; 1993 May; 16(5):448-52. PubMed ID: 8364489
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fibrinopeptide release from fibrinogen.
    Nossel HL; Hurlet-Jensen A; Liu CY; Koehn JA; Canfield RE
    Ann N Y Acad Sci; 1983 Jun; 408():269-78. PubMed ID: 6223557
    [No Abstract]   [Full Text] [Related]  

  • 29. Steady state kinetic parameters for the thrombin-catalyzed conversion of human fibrinogen to fibrin.
    Higgins DL; Lewis SD; Shafer JA
    J Biol Chem; 1983 Aug; 258(15):9276-82. PubMed ID: 6409903
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A new congenital abnormal fibrinogen Ise characterized by the replacement of B beta glycine-15 by cysteine.
    Yoshida N; Wada H; Morita K; Hirata H; Matsuda M; Yamazumi K; Asakura S; Shirakawa S
    Blood; 1991 May; 77(9):1958-63. PubMed ID: 2018836
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thrombin-induced fibrinopeptide B release from normal and variant fibrinogens: influence of inhibitors of fibrin polymerization.
    Ruf W; Bender A; Lane DA; Preissner KT; Selmayr E; Müller-Berghaus G
    Biochim Biophys Acta; 1988 May; 965(2-3):169-75. PubMed ID: 3365451
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fibrin assembly. Lateral aggregation and the role of the two pairs of fibrinopeptides.
    Weisel JW
    Biophys J; 1986 Dec; 50(6):1079-93. PubMed ID: 3801570
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endothelial cell responses to fibrin mediated by FPB cleavage and the amino terminus of the beta chain.
    Francis CW; Bunce LA; Sporn LA
    Blood Cells; 1993; 19(2):291-306; discussion 306-7. PubMed ID: 8312565
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Direct evidence for specific interactions of the fibrinogen alphaC-domains with the central E region and with each other.
    Litvinov RI; Yakovlev S; Tsurupa G; Gorkun OV; Medved L; Weisel JW
    Biochemistry; 2007 Aug; 46(31):9133-42. PubMed ID: 17630702
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A kinetic model for the alpha-thrombin-catalyzed conversion of plasma levels of fibrinogen to fibrin in the presence of antithrombin III.
    Naski MC; Shafer JA
    J Biol Chem; 1991 Jul; 266(20):13003-10. PubMed ID: 2071587
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The polymerization and thrombin-binding properties of des-(B beta 1-42)-fibrin.
    Siebenlist KR; DiOrio JP; Budzynski AZ; Mosesson MW
    J Biol Chem; 1990 Oct; 265(30):18650-5. PubMed ID: 2211727
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thrombin cleavage enhances exposure of a heparin binding domain in the N-terminus of the fibrin beta chain.
    Odrljin TM; Shainoff JR; Lawrence SO; Simpson-Haidaris PJ
    Blood; 1996 Sep; 88(6):2050-61. PubMed ID: 8822924
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of structures of various human fibrinogens and a derivative thereof by a study of the kinetics of release of fibrinopeptides.
    Hanna LS; Scheraga HA; Francis CW; Marder VJ
    Biochemistry; 1984 Sep; 23(20):4681-7. PubMed ID: 6238619
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The localization of tissue factor and apolipoprotein(a) in atherosclerotic lesions of the human aorta and their relation to fibrinogen-fibrin transition.
    Ichikawa K; Nakagawa K; Hirano K; Sueishi K
    Pathol Res Pract; 1996 Mar; 192(3):224-32. PubMed ID: 8739469
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Conformational and structural modulation of the NH2-terminal regions of fibrinogen and fibrin associated with plasmin cleavage.
    Edgington TS; Plow EF
    J Biol Chem; 1975 May; 250(9):3393-8. PubMed ID: 47328
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.